(Q35673260)

English

Biweekly rituximab, cyclophosphamide, vincristine, non-pegylated liposome-encapsulated doxorubicin and prednisone (R-COMP-14) in elderly patients with poor-risk diffuse large B-cell lymphoma and moderate to high 'life threat' impact cardiopathy

scientific article published on 28 June 2011

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21707585%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Biweekly rituximab, cyclophosphamide, vincristine, non-pegylated liposome-encapsulated doxorubicin and prednisone (R-COMP-14) in elderly patients with poor-risk diffuse large B-cell lymphoma and moderate to high 'life threat' impact cardiopathy (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21707585%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

B-cell lymphoma

1 reference

based on heuristic

inferred from title

diffuse large B-cell lymphoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

7

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21707585%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

Gaetano Corazzelli

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21707585%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Ferdinando Frigeri

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21707585%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Manuela Arcamone

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21707585%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Anna Lucania

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21707585%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Maria Rosariavilla

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21707585%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Emanuela Morelli

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21707585%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Gaetana Capobianco

8

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21707585%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Antonietta Caronna

9

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21707585%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Cristina Becchimanzi

10

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21707585%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Francesco Volzone

11

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21707585%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Gianpaolo Marcacci

12

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21707585%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Filippo Russo

13

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21707585%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Rosaria De Filippi

14

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21707585%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Lucia Mastrullo

15

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21707585%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Antonio Pinto

16

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21707585%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

language of work or name

0 references

publication date

28 June 2011

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21707585%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

British Journal of Haematology

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21707585%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

154

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21707585%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21707585%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

579-589

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21707585%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Anthracycline cardiotoxicity in the elderly cancer patient: a SIOG expert position paper.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3258483

12 July 2018

Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3258483

12 July 2018

Cardiovascular toxicity caused by cancer treatment: strategies for early detection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3258483

12 July 2018

Long-term results of gemcitabine plus oxaliplatin with and without rituximab as salvage treatment for transplant-ineligible patients with refractory/relapsing B-cell lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3258483

12 July 2018

American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3258483

12 July 2018

Aspects of chemotherapy schedules in young and elderly patients with aggressive lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3258483

12 July 2018

Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3258483

12 July 2018

Lymphoma in older patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3258483

12 July 2018

Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3258483

12 July 2018

CHOP-rituximab with pegylated liposomal doxorubicin for the treatment of elderly patients with diffuse large B-cell lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3258483

12 July 2018

Anthracycline-induced cardiotoxicity in adult hematologic malignancies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3258483

12 July 2018

Pathogenesis of cardiotoxicity induced by anthracyclines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3258483

12 July 2018

Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3258483

12 July 2018

Advantages of liposomal delivery systems for anthracyclines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3258483

12 July 2018

An electronic application for rapidly calculating Charlson comorbidity score

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3258483

12 July 2018

Drugs that cause Torsades de pointes and increase the risk of sudden cardiac death

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3258483

12 July 2018

ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 G

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3258483

12 July 2018

Pegylated liposomal doxorubicin in the CHOP regimen for older patients with aggressive (stages III/IV) non-Hodgkin's lymphoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3258483

12 July 2018

Early decline in left ventricular ejection fraction predicts doxorubicin cardiotoxicity in lymphoma patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3258483

12 July 2018

Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized, multicenter trial of metastatic breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3258483

12 July 2018

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3258483

12 July 2018

Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapy. Seven-year experience using serial radionuclide angiocardiography

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3258483

12 July 2018

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3258483

12 July 2018

Non-Hodgkin's lymphoma in patients 80 years of age or older

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08786.X

21 January 2018

Revised response criteria for malignant lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08786.X

21 January 2018

Doxorubicin, cardiac risk factors, and cardiac toxicity in elderly patients with diffuse B-cell non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08786.X

21 January 2018

Importance of maintaining the relative dose intensity of CHOP-like regimens combined with rituximab in patients with diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08786.X

21 January 2018

Liposome-encapsulated doxorubicin in combination with standard agents (cyclophosphamide, vincristine, prednisone) in patients with newly diagnosed AIDS-related non-Hodgkin's lymphoma: results of therapy and correlates of response

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08786.X

21 January 2018

Early cardiotoxicity of the CHOP regimen in aggressive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08786.X

21 January 2018

Nonpegylated liposomal doxorubicin (MyocetTM) combination (R-COMP) chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL): results from the phase II EUR018 trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08786.X

21 January 2018

The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08786.X

21 January 2018

Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08786.X

21 January 2018

R-CHOP-14 in patients with diffuse large B-cell lymphoma younger than 70 years: a multicentre, prospective study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08786.X

21 January 2018

A resurgence of Pneumocystis in aggressive lymphoma treated with R-CHOP-14: the price of a dose-dense regimen?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08786.X

21 January 2018

Non-Hodgkin's lymphoma in very elderly patients over 80 years. A descriptive analysis of clinical presentation and outcome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08786.X

21 January 2018

R-COMP 21 for frail elderly patients with aggressive B-cell non-Hodgkin lymphoma: a pilot study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08786.X

21 January 2018

Standard International prognostic index remains a valid predictor of outcome for patients with aggressive CD20+ B-cell lymphoma in the rituximab era.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08786.X

21 January 2018

Factors associated with early termination of CHOP therapy and the impact on survival among patients with chemosensitive intermediate-grade non-Hodgkin's lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3258483

25 September 2018

Comorbidity and age as predictors of risk for early mortality of male and female colon carcinoma patients: a population-based study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3258483

25 September 2018

ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08786.X

21 January 2018

Liposome-encapsulated doxorubicin in combination with cyclophosphamide, vincristine, prednisone and rituximab in patients with lymphoma and concurrent cardiac diseases or pre-treated with anthracyclines

1 reference

https://pubmed.ncbi.nlm.nih.gov/21707585

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Usefulness of myocardial performance index and biochemical markers for early detection of anthracycline-induced cardiotoxicity in adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/21707585

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monitoring of the very early changes of left ventricular diastolic function in patients with acute leukemia treated with anthracyclines

1 reference

https://pubmed.ncbi.nlm.nih.gov/21707585

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Myocardial necrosis in ICU patients with acute non-cardiac disease: a prospective study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21707585

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiac troponins I and T are biological markers of left ventricular dysfunction in septic shock

1 reference

https://pubmed.ncbi.nlm.nih.gov/21707585

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elevation of troponin I in sepsis and septic shock

1 reference

https://pubmed.ncbi.nlm.nih.gov/21707585

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiovascular trials in long-term survivors of childhood cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21707585

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drugs and the QT interval - caveat doctor

1 reference

https://pubmed.ncbi.nlm.nih.gov/21707585

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incorporating toxicity considerations into the design of two-stage phase II clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/21707585

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elevation of serum cardiac troponin I in noncardiac and cardiac diseases other than acute coronary syndromes

1 reference

https://pubmed.ncbi.nlm.nih.gov/21707585

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiotoxicity after liposomal anthracyclines

1 reference

https://pubmed.ncbi.nlm.nih.gov/21707585

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A population-based study of severity of comorbidity among patients with non-Hodgkin's lymphoma: prognostic impact independent of International Prognostic Index

1 reference

https://pubmed.ncbi.nlm.nih.gov/21707585

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outcomes and diffusion of doxorubicin-based chemotherapy among elderly patients with aggressive non-Hodgkin lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21707585

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1365-2141.2011.08786.X

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21707585%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21707585%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21707585%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35673260&oldid=2174512855"